DROXIA 6337 DROXIA 6337 Pill - orange capsule/oblong, 22mm

Generic Name: hydroxyurea

Pill with imprint DROXIA 6337 DROXIA 6337 is Orange, Capsule/Oblong and has been identified as Droxia 400 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of Sickle Cell Anemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6337 DROXIA 6337

Droxia

Generic Name: hydroxyurea
Imprint: DROXIA 6337 DROXIA 6337
Strength: 400 mg
Color: Orange
Size: 22.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Antimetabolites
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bristol-Myers Squibb
National Drug Code (NDC): 00003-6337
Inactive Ingredients: citric acid monohydrate, gelatin, magnesium stearate, sodium phosphate, titanium dioxide, D&C Red No. 28, D&C Red No. 33, D&C Yellow No. 10
Note: Inactive ingredients may vary.